Kaiwen Wang

机构：The University of Texas MD Anderson Cancer Center, Capital Medical University, Shanghai University of Traditional Chinese Medicine, Seventh People's Hospital of Shanghai, Beijing Friendship Hospital · ORCID：0000-0003-2881-8181

发表论文 31 篇 · 总被引 155 次 · h-index 7

代表论文

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC (2023 · Journal of Thoracic Oncology · 被引 26)
Receptor Tyrosine Kinase Fusion-Mediated Resistance to EGFR TKI in EGFR-Mutant NSCLC: A Multi-Center Analysis and Literature Review (2024 · Journal of Thoracic Oncology · 被引 20)
Safety and Intracranial Activity of Adagrasib in Patients With KRAS G12C -Mutated Non–Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial: A Case Series (2024 · JCO Precision Oncology · 被引 10)
Safety and efficacy of early versus delayed acetylsalicylic acid after surgery for spontaneous intracerebral haemorrhage in China (E-start): a prospective, multicentre, open-label, blinded-endpoint, randomised trial (2024 · The Lancet Neurology · 被引 9)
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC (2023 · JTO Clinical and Research Reports · 被引 8)
Treatment of lung cancer by acupuncture combined with medicine based on pathophysiological mechanism: A review (2024 · Medicine · 被引 7)